Optimization of pre-analytical variables affecting the accuracy of hemoglobin A1c measurement in point-of-care devices.

Project Abstract

This study investigates the influence of pre-analytical variables on the accuracy of hemoglobin A1c (HbA1c) measurements obtained from point-of-care (POC) devices, a critical concern for diabetes diagnosis, monitoring, and therapeutic decision-making. By systematically examining specimen collection, handling, storage, and transport conditions, we aim to quantify the extent to which deviations from standard procedures may bias results and to propose practical, evidence-based mitigation strategies suitable for clinical and community settings. A mixed-methods approach was adopted, combining quantitative experimental design with qualitative observations from frontline users to capture real-world pre-analytical challenges. We collected capillary and venous blood samples from a diverse patient cohort spanning multiple age groups, glycemic statuses, and hematological profiles, ensuring representative variability encountered in routine practice. Samples were subjected to controlled variations in key pre-analytical factors, including time-to-analysis intervals, anticoagulant type and concentration, hematocrit effects, ambient temperature and transport conditions, sample volume, finger-prick technique, and storage duration prior to POC testing. HbA1c measurements were performed using two widely used POC devices and compared against reference laboratory methods considered the gold standard for accuracy. Analytical performance metrics, including bias, precision, limit of agreement, and concordance rates across clinically relevant HbA1c thresholds, were calculated using Bland-Altman plots and Deming regression. Multivariate analysis identified the most impactful pre-analytical variables and interaction effects, while subgroup analyses explored the influence of patient-specific factors such as anemia, high red cell turnover, and recent transfusion history on measurement accuracy. To ensure clinical relevance, we integrated a risk-scoring framework that flags samples likely to yield unreliable results due to pre-analytical deviations, enabling immediate corrective actions at the point of care. The study also evaluated device-specific responses to pre-analytical stressors, highlighting the need for device manufacturers to incorporate robust pre-analytical QC checks and user-friendly guidelines. Findings indicate that delays in analysis beyond recommended windows, improper sample volumes, extreme temperature exposure, and use of suboptimal anticoagulants significantly distort HbA1c values, with variability amplified in samples with atypical hematocrit or hemoglobinopathy traits. The magnitude of bias varied between devices, underscoring the necessity for device-specific pre-analytical validation and standardization across laboratories and clinics. Based on these results, we propose a set of standardized pre-analytical protocols, practical training modules for healthcare workers, and a decision-support checklist tailored for POC testing environments. The implications of this work extend to improved diagnostic accuracy, better disease monitoring, and reduced risk of misclassification that could lead to inappropriate treatment changes. By addressing a critical gap in pre-analytical quality control, the study provides actionable recommendations to enhance the reliability of HbA1c POCT results and informs future device development, regulatory guidelines, and clinical practice standards.

Project Overview

What This Project Is About

---

A plain-language overview of how pre-analytic steps can influence the accuracy of HbA1c results from point-of-care devices. The project looks at the moments before the test is run—like how samples are collected, stored, and handled—and how these steps might change the reading you get from a handheld device compared to standard lab methods.

---

---

The Problem It Addresses

---

In many clinics, quick HbA1c readings guide treatment decisions. If pre-analytic steps are inconsistent, results can be wrong, leading to misdiagnosis or poor management of diabetes. This project investigates common sources of error before analysis and how to minimize them.

---

---

Objectives of the Project

---

1. Identify key pre-analytic factors that affect HbA1c readings on point-of-care devices.
2. Compare results from point-of-care devices with standard laboratory methods under various handling conditions.
3. Recommend practical best practices for sample collection, storage, and handling in clinics.
4. Evaluate the impact of pre-analytic variations on decision-making thresholds used in diabetes care.

---

---

What You Will Do Step by Step

---

1. Review existing literature on pre-analytic variables for HbA1c testing.
2. Design a study using simulated and real clinic samples with controlled handling conditions.
3. Perform HbA1c measurements with point-of-care devices and reference methods.
4. Analyze how different pre-analytic factors change results using basic statistics.
5. Assess agreement and clinically relevant differences between methods.
6. Develop practical guidelines for clinics based on findings.

---

---

Expected Outcome

Clear evidence on which pre-analytic steps most affect HbA1c accuracy in point-of-care devices, plus actionable recommendations to reduce error and improve patient care.